Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-20

FDA Approved: DICLOFENAC SODIUM 1.5% — Original Application (SOLA Pharmaceuticals)

View source ↗

Summary

FDA approved the Original Application for DICLOFENAC SODIUM 1.5% topical from SOLA Pharmaceuticals, a generic diclofenac topical product for relief of osteoarth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DICLOFENAC SODIUM 1.5% (diclofenac sodium topical)

Snippet

ORIG AP for DICLOFENAC SODIUM 1.5% (DICLOFENAC SODIUM TOPICAL)